\n<\/p>\n
According to the latest research by InsightAce Analytic, the Global Precision Diagnostics & Medicine Market is valued at USD 138.4 Bn in 2024 , and it is expected to reach USD 425.9 Bn by 2034 , with a CAGR of 12.3% during the forecast period of 2025-2034.<\/p>\n
Global Precision Diagnostics and Medicine Market 2025-2034 full Research Repot latest version is now available.<\/p>\n
Get Free Access to Demo Report, Excel Pivot and ToC: https:\/\/www.insightaceanalytic.com\/request-sample\/3040<\/a><\/p>\n Precision diagnostics & medicine is a fast-emerging field that focuses on tailoring medical therapies and diagnostic procedures to the individual characteristics of each patient. To provide more accurate and customized healthcare treatments, cutting-edge technologies such as genomics, proteomics, and biomarkers must be utilized. <\/p>\n This approach aims to increase therapy effectiveness by considering the behavioural, environmental, and genetic factors that influence a patient’s health. The precision diagnostics and medicine market is expanding due to factors such as the increasing use of AI and ML to enhance precision diagnostics and medicine development, the growing collaboration between pharmaceutical and diagnostics companies to improve precision healthcare, and the rise in direct-to-consumer testing. <\/p>\n Additionally, the increased use of wearable technology to improve precision healthcare and the expansion of precision healthcare applications into additional disease areas present potential prospects for market participants. Establishing production and research centres in developing nations is another way major competitors in the precision diagnostics & medicine market are expanding their global reach.<\/p>\n List of Prominent Players in the Precision Diagnostics & Medicine Market:<\/p>\n \u0095\tF. Hoffmann-La Roche Ltd Expert Knowledge, Just a Click Away: https:\/\/calendly.com\/insightaceanalytic\/30min?month=2025-04<\/a><\/p>\n Market Dynamics: Additionally, the use of precision diagnostics has been facilitated by the shift toward value-based care, which focuses on improving patient outcomes while reducing costs. Furthermore, regulatory support\u0097such as health authorities’ clearance of precision therapies\u0097and rising patient awareness of personalized medicine are key factors driving market expansion.<\/p>\n Challenges: Furthermore, gathering non-clinical and real-world data for evidence generation raises the price. Precision medications, like Kymriah, a CAR-T therapy from Novartis AG, demand significant R&D expenditures, which raises the drug’s price and renders it expensive for patients. Additionally, the cost of the infrastructure needed for data collecting and genomic testing is another barrier to the widespread use of these treatments.<\/p>\n Regional Trends: Both substantial R&D investment and government initiatives to improve healthcare quality and accessibility have contributed to the industry’s expansion. Besides, over the projection period, Asia Pacific is expected to increase at the fastest rate ascribed to the increased need for precision diagnostics solutions brought on by the region’s rising rates of cancer, genetic abnormalities, and chronic illnesses. Investments in healthcare infrastructure in nations like China, India, and Japan are helping to support this expansion by improving access to cutting-edge diagnostic tools.<\/p>\n Unlock Your GTM Strategy: https:\/\/www.insightaceanalytic.com\/customisation\/3040<\/a><\/p>\n Recent Development: Segmentation of Precision Diagnostics & Medicine Market- Read Overview Report- https:\/\/www.insightaceanalytic.com\/report\/precision-diagnostics–medicine-market\/3040<\/a><\/p>\n About Us: Contact us:
\u0095\tEli Lilly and Company
\u0095\tPfizer Inc.
\u0095\tGSK plc.
\u0095\tSanofi
\u0095\tJohnson & Johnson Services, Inc.
\u0095\tVertex Pharmaceuticals Incorporated
\u0095\tAgilent Technologies, Inc.
\u0095\tThermo Fisher Scientific Inc.
\u0095\tMyriad Genetics, Inc.
\u0095\tGuardant Health
\u0095\tAbbott
\u0095\tAstraZeneca
\u0095\tAbbVie Inc.
\u0095\tAmgen Inc.
\u0095\tMerck KgaA
\u0095\tSarepta Therapeutics, Inc.
\u0095\tMerck & Co., Inc.
\u0095\tNatera, Inc.
\u0095\tARUP Laboratories
\u0095\tDevyser
\u0095\tDiasorin S.P.A.
\u0095\tTempus
\u0095\tIllumina, Inc.
\u0095\tDanaher
\u0095\tExact Sciences Corporation
\u0095\tQiagen
\u0095\t23andME, INC.
\u0095\tTrinity Biotech Plc.
\u0095\tAmoy Diagnostics Co., Ltd.
\u0095\tNovartis AG
\u0095\tBristol-Myers Squibb Company
\u0095\tGilead Sciences, Inc
\u0095\tPillar Biosciences Inc.
\u0095\tInvivoscribe, Inc.
\u0095\tNeuroCode
\u0095\tC2N Diagnostics<\/p>\n
Drivers-
Developments in genetic research drive the market for precision diagnostics and medicine, including falling sequencing technology costs and increased funding for innovative healthcare practices. Precision medicine can now completely transform healthcare, given that genetic data is increasingly complete and easily accessible. <\/p>\n
One major barrier to the widespread use of precision medicines and diagnostic kits is the expensive cost of precision healthcare. Because precision medicines rely on genetic testing to identify particular medication biomarkers, their research and development costs are far higher than those of standard therapies. <\/p>\n
The North American Precision Diagnostics & Medicine market is anticipated to register a major market share in terms of revenue driven by its advanced medical facilities and strong biotechnology research fields. Investments in these areas continue to yield innovations that enhance the reliability and efficacy of personalized diagnostics technology. <\/p>\n
\u0095\tNovember 2024: The CE Mark was awarded to Roche for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, which is intended to determine which patients with epithelial ovarian cancer (EOC) are suitable for ELAHERE (mirvetuximab soravtansine) treatment for FR\u03b1-positive platinum-resistant ovarian cancer.
\u0095\tAugust 2024: The first AI-driven video analysis tool in the market was unveiled by Healthians, a diagnostic firm located in India. It helps customers navigate their health reports by highlighting important health characteristics and elucidating their relevance. After completing a quick survey on the Healthians app, users can obtain individualized insights within 15 to 30 minutes thanks to this cutting-edge function, which improves their capacity to make health-related decisions.<\/p>\n
Precision Diagnostics & Medicine Market-By Type
\u0095\tGenetic Testing
\u0095\tDTC Testing
\u0095\tOthers
Precision Diagnostics & Medicine Market-By Product
\u0095\tMonoclonal Antibodies
\u0095\tInhibitor Drugs
\u0095\tCell & Gene Therapies
\u0095\tAntiviral & Anti- Retroviral Drugs
\u0095\tOthers
Precision Diagnostics & Medicine Market-By Indication
\u0095\tDiagnostics
o\tOncology
o\tNeurology
o\tImmunology
o\tOthers
\u0095\tMedicine
o\tOncology
o\tRare Diseases
o\tInfectious Diseases
o\tHematological Disorders
o\tOthers
Precision Diagnostics & Medicine Market-By End-User
\u0095\tClinical Laboratories
\u0095\tHospitals
\u0095\tHome Care Settings
Precision Diagnostics & Medicine Market-By Region
North America-
\u0095\tThe US
\u0095\tCanada
Europe-
\u0095\tGermany
\u0095\tThe UK
\u0095\tFrance
\u0095\tItaly
\u0095\tSpain
\u0095\tRest of Europe
Asia-Pacific-
\u0095\tChina
\u0095\tJapan
\u0095\tIndia
\u0095\tSouth Korea
\u0095\tSouth East Asia
\u0095\tRest of Asia Pacific
Latin America-
\u0095\tBrazil
\u0095\tMexico
\u0095\tRest of Latin America
Middle East & Africa-
\u0095\tGCC Countries
\u0095\tSouth Africa
\u0095\tRest of the Middle East and Africa<\/p>\n
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.<\/p>\n
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com<\/a>
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com <\/p>\n<\/div>\n